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Abstract
Thyroid is particularly prone to morphogenetic variability. De-
velopmental failure of the thyroid gland is in 85% of cases the 
underlying cause of congenital hypothyroidism, diagnosed at 
birth with a frequency of 1:3000–1:4000 newborns. However, the 
incidence of less severe developmental variants of the thyroid 
is much higher. Determination of the aetiology of congenital 
hypothyroidism is crucial for predicting its severity and outcome 
as well as impacts dose of L-thyroxine during substitution. Thy-
roid imaging is necessary to establish diagnosis, and it involves 
mainly thyroid ultrasound examination and scintiscan. Aware-
ness of both the advantages and limitations of sonographic and 
scintigraphic imaging are central to the successful interpretation 
of their results and reasonable recommendation of these pro-
cedures for patients with thyroid developmental anomalies of 
different age and clinical picture. Hence, the aim of this review 
is to provide the most important and up-to-date information 
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Introduction
Thyroid gland is particularly prone to morphogenetic variabil-
ity. The total incidence of thyroid developmental abnormalities in 
the population is difficult to assess. The occurrence of thyroid 
gland anomalies leading to congenital hypothyroidism (CH) can 
be estimated on the basis of data from newborn TSH screening 
[1]. However, the incidence of asymptomatic developmental vari-
ants of thyroid morphogenesis, usually not manifesting clinically, 
remains unknown. Anatomical variants like thyroid haemiagenesis, 
accessory thyroid, thyroglossal duct cyst, or pyramidal lobe, if 
not associated with local symptoms or disturbances in thyroid 
hormonal function, usually remain undiagnosed.
The aim of this review is to provide the most important and 
up-to-date information on the place of radionuclide scanning 
and ultrasonography in visualization of thyroid developmental 
abnormalities.  
Congenital hypothyroidism 
— definition and diagnosis
Congenital hypothyroidism is defined as thyroid hormone 
deficiency present at birth. It occurs in Europe with a frequency 
of 1:3000–1:4000 newborns [2–4]. Nowadays, in most developed 
countries, CH is diagnosed by neonatal screening [5]. Blood 
is collected on the third day after birth and abnormal results of 
TSH concentration tests mean the child is recalled for further 
evaluation. The subsequent diagnostic tests involve confirmation 
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of the diagnosis, which comprises repeated TSH measurement 
as well as additional serum thyroxine and thyroglobulin assess-
ment [6]. The diagnosis of CH is followed by immediate intro-
duction of L-thyroxine substitution. The treatment is continued 
throughout at least the first three years of life, which are crucial 
for neuropsychological development. Therapy may be discon-
tinued when diagnosis of transient CH is made after a four-week 
trial of L-thyroxine withdrawal, or maintained lifelong if temporary 
suspension of substitution results in confirmation of the perma-
nent form of CH [7]. The most common causes of CH are thyroid 
developmental anomalies. Thyroid dysgenesis, responsible for 
inappropriate results of neonatal TSH screening tests in 85% of 
cases, involves thyroid agenesis, ectopy and hypoplasia, and 
less frequently thyroid haemiagenesis. A second common cause 
of CH is dyshormonogenesis, which is responsible for 10–15% of 
cases diagnosed [1, 8].
Why is it so important to establish 
the aetiology of congenital hypothyroidism?
Some clinicians believe that, since the management of CH 
is the same regardless of its origin, establishing the cause of CH 
is not obligatory. Such an opinion is based on the conviction that 
imaging, especially with radionuclide isotopes, may be harmful 
to children. What is more, as the thyroid scintiscan should be 
performed under conditions of endogenous TSH stimulation, it 
might result in an unnecessary delay in treatment introduction. 
Meanwhile, determination of the aetiology of CH seems as im-
portant as treatment. However, to establish diagnosis, thyroid 
imaging is necessary, which mainly involves thyroid ultrasound 
examination and scintiscan.
Studies have demonstrated that athyreotic children present 
worse neuropsychological development in comparison to children 
with thyroid hypoplasia, ectopy, or dyshormonogenesis, and hence 
require higher doses of L-thyroxine [9–12]. Thus, the determina-
tion of CH aetiology is crucial for predicting its severity, outcome 
as well as impacts L-thyroxine titration. The aetiopathogenesis of 
thyroid dysgenesis is still unknown [1]. Genetic factors were proven 
to have a causative role in only 2% of cases. Moreover, thyroid 
developmental abnormalities are probably of multifactorial origin, 
and Mendelian transmission almost never happens [13]. Thus, 
most cases occur sporadically, and the risk for the second child 
of a couple to be born with thyroid developmental failure is close 
to that of the general population. On the other hand, dyshormono-
genesis is usually inherited in an autosomal recessive manner; 
hence, the risk for another child is 25%. Therefore, differentiation 
of the cause of CH is particularly important to ascertain reliable 
parental genetic counselling [6]. 
The role of thyroid scintigraphy and 
ultrasonography in determining the 
aetiology of congenital hypothyroidism
Ultrasound examination
Recent years have brought about widespread use of ultra-
sound techniques in the diagnostics of the thyroid gland. The 
technical development of sonographic imaging has converged 
together with its increasing accessibility [14]. The low cost of the 
examination also plays an important role in its availability. Imaging 
in CH primarily involves ultrasound examination, which requires no 
preparation, and can thus be performed and repeated at any time, 
without interruption of treatment. It allows repeatable, real-time, and 
non-invasive assessment of the thyroid morphology. This is also 
a rapid, safe, and comfortable examination. It does not expose 
patients to radioactive isotopes or Roentgen radiation and so 
can be performed with no harm in children at any age. With the 
employment of colour Doppler technique, enabling visualization 
of tissue vascularisation, the thyroid can easily be discriminated 
from other surrounding tissues [15]. Ultrasound examination 
does, however, provide entirely morphological information and no 
conclusions pertaining to the hormonal function of the observed 
structures can be derived on the basis of this examination. Sonog-
raphy is also useful due to its high sensitivity in the detection of 
thyroid pathologies. It allows the demonstration of pathological 
conditions accompanying thyroid developmental anomalies, i.e. 
concomitant focal lesions as well as autoimmune or neoplastic 
processes.
Despite its unquestionable advantages, this examination also 
has several limitations. The ultrasound waves do not penetrate 
through calcified structures; hence, sonographic assessment of 
ectopic thyroid in retrosternal, intralaryngeal, or intratracheal loca-
tions is largely limited. Although some of the features of thyroid 
tissue detected exclusively on the basis of ultrasound examination 
augment the suspicion of a malignant transformation, the differentia-
tion between a benign and a malignant lesion cannot be performed 
entirely on the basis of ultrasonographic assessment. Finally, it must 
be remembered how crucial the quality of the equipment used for 
the examination and the experience of the sonographer are for the 
credibility and reproducibility of this examination [14]. Additionally, 
the interpretation of sonographic pictures taken from neonates re-
quires broad experience and awareness of specificities of paedi-
atric head and neck anatomy. For the inexperienced sonographer, 
other anatomical structures as the thymus, oesophagus, or lymph 
nodes might be misdiagnosed as thyroid gland [16]. Moreover, 
worse cooperation of a young patient is another factor influencing 
the quality and reliability of the examination. The minimal technical 
requirements should also be fulfilled, and a linear probe of 7.5 MHz 
or higher frequency ought to be used. It is important that the whole 
region of the neck is scanned in searching for the presence of 
ectopic thyroid tissue. However, one of the significant limitations of 
ultrasonography is poor sensitivity in visualization of ectopic thyroid, 
if compared to radionuclide scanning [17, 18].
Diagnosis of thyroid of normal size or goitre on ultrasound 
examination is suggestive of dyshormonogenesis or transient CH 
due to prenatal exposure to excessive iodine, antithyroid drugs, 
or TSH receptor (TSH-R) blocking autoantibodies. However, dis-
criminating is thyroid scintiscan.
The study of Beltrao et al. revealed close concordance of di-
agnoses established by scintiscan and ultrasonography [16]. The 
discordance, at a level of 18%, mainly concerned cases diagnosed 
as thyroid agenesis on ultrasound examination while the scintiscan 
revealed the presence of ectopic thyroid. 
Scintigraphy
Some authors support the idea of performing the diagnostic 
scintiscan in the neonatal period before L-thyroxine is administered, 
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during the period of natural endogenous TSH stimulation. The 
need for establishing the reason for CH should not result in delay 
in treatment as TSH concentration in subjects with confirmed CH 
is markedly elevated (usually above 100 μIU/ml) and remains el-
evated for many days after onset of treatment, during which time 
scintigraphy can be performed [19]. Whereas sonographic as-
sessment of even new-born children is considered harmless, ap-
plication of radioisotopes for scanning in neonates still raises many 
controversies due to unknown implications of exposure to radiation 
at such a young age. Nevertheless, 123I thyroid imaging has been 
used for many decades without evidence of risk for thyroid cancer.
Permanent CH can be assumed if ultrasonography or ra-
dionuclide imaging shows an absent or ectopic thyroid gland, 
consistent with athyreosis or thyroid dysgenesis, one demonstrate 
dyshormonogenesis, or if at any time during the first year of life the 
serum TSH rises above 20 μIU/l due to undertreatment. If perma-
nent CH has not been established by two to three years of age, the 
American Academy of Pediatrics (AAP) and the European Society 
of Paediatric Endocrinology (ESPE) recommend a 30-day trial off 
L-thyroxine therapy [20, 21]. In most guidelines it is recommended 
that scintiscan be performed optionally at the age of three years, 
during temporary L-thyroxine substitution withdrawal, which is also 
necessary to differentiate subjects with transient and permanent 
forms of CH. The cessation of L-thyroxine treatment should last for 
at least four weeks and the child is also recommended to follow 
a low-iodine diet for at least two weeks preceding the examination. 
Thus, the procedure is not recommended at the developmental 
age below three years, due to potential devastating consequenc-
es on neuropsychological development. Hence, the establishing 
of CH diagnosis associated with temporary L-thyroxine withdrawal 
is advised at the age of three to five. What is also important, coop-
eration with the patient during the examination at a more advanced 
age is also much easier. Some authors suggest that radionuclide 
scan should be performed on TSH stimulation without L-thyroxine 
withdrawal as human recombinant TSH (hr-TSH) has not yet been 
registered for this purpose [22, 23]. With the expected availability 
of rh-TSH, testing for recovery of the gland will be easier and 
safer. Indeed, without discontinuing replacement therapy, thyroid 
imaging with 123I performed after rh-TSH injection will indicate if 
a gland is present orthotopically with acceptable size and uptake, 
which will allow for safe discontinuation of exogenous L-thyroxine. 
In contrast to ultrasonography, the great advantage of scin-
tigraphy lies in its effectiveness in identification of functioning 
thyroid tissue. Additionally, some general conclusions on thyroid 
presence, localization, and size may also be derived on the ba-
sis of scintiscan. Hence, it allows cases of thyroid agenesis to be 
differentiated from ectopy or hypoplasia.
The radionuclides used in diagnostics of CH are 123I and tech-
netium 99Tc pertechnetate (TcP). To perform scintigraphy with 123I, 
30 to 50 μCi [(1.11–1.85) × 106 Bq] of 123I is administered orally 
and an uptake image is taken in 3 to 6 hours and, if necessary, 
another image in 24 hours. For technetium imaging, 0.5 to 1 mCi 
[(1.85–3.7) × 107 Bq] of TcP is administered intravenously and 
an image is taken 20 minutes later; hence it provides almost im-
mediate information in comparison to longer and more complex 
procedure of 123I scintiscan. The use of 131I is controversial due 
to the relatively large dose of radioisotope administered during 
examination [6, 19].
In the study by Schoen et al., among 210 infants with CH, nor-
mal thyroid was diagnosed more often by 123I scintigraphy (49%) 
in comparison to TcP scintiscan (31% of cases) [19]. Hence, the 
use of TcP might lead to misdiagnosis of thyroid dysgenesis in 
cases where eutopic thyroid was visualized when 123I had been 
used. This might have significant implications on parental counsel-
ling about the certainty of permanent forms of CH and the pos-
sibility of discontinuation of L-thyroxine substitution in the future.
Recommendations suggest preferential use of 123I due to the 
specificity of this radionuclide to be trapped entirely in thyroid cells, 
while TcP is taken up by multiple tissues, including salivary glands, 
which might disturb the interpretation of scintigraphic pictures, 
especially in the case of thyroid ectopy. Another advantage of 123I 
is its specific affinity to thyrocytes, meaning that radiation absorbed 
during 123I scintigraphy is limited to the thyroid tissue. The total body 
irradiation is three times lower than that of a chest radiographic 
evaluation and equivalent to the amount of radiation received dur-
ing a round-trip (10-hour) transcontinental flight on a commercial 
airline or during one month living at sea level [19]. 123I thyroid scin-
tigraphy may also be helpful in defining underlying mechanisms of 
dyshormonogenesis. Unfortunately, 123I is more expensive than TcP 
and must be ordered in advance, while TcP is routinely stocked by 
nuclear medicine departments and is thus more easily available 
than 123I. It is believed that the results of TcP scintiscans are valid 
only for findings of eutopic or absent thyroid glands. However, on 
scintiscans with TcP thyroid ectopy is more prevalently diagnosed, 
while less frequently eutopic thyroid is described [24].
It is recommended that in assessment of CH, imaging stu-
dies should be compared to thyroglobulin concentration levels, 
which are a biochemical marker of the amount of thyroid tissue. 
When the level of thyroglobulin is undetectable, radionuclide scan-
ning may be avoided and complete thyroid agenesis should be 
diagnosed. Inversely, subjects presenting with normal or enlarged 
thyroid gland accompanied by low or undetectable thyroglobulin 
levels raise suspicion of thyroglobulin deficiency [6].
Large thyroid of eutopic localization presenting increased 
radioisotope uptake suggests dyshormonogenesis, with exclusion 
of iodide trapping. In determining the type of dyshormonogenesis, 
perchlorate discharge test and genetic studies might be helpful 
[6, 19].
Some authors suggest that radionuclide scanning can be 
replaced with less harmful examinations, including ultrasonog-
raphy and thyroglobulin assessment, while radioisotope imaging 
should be restricted to cases in which non-invasive diagnostic 
techniques failed to establish diagnosis. A serious limitation of 
the radionuclide scan is that the absence of radioisotope uptake, 
mimicking thyroid agenesis, can also be observed in TSH-R gene 
mutations, iodide trapping defects, and transient CH in children 
born from mothers with anti-TSH-R blocking antibodies (TRAb), 
mothers on antithyroid drugs, or mothers exposed to excessive 
iodine. Hence, only thyroid ultrasonography or biochemical stu-
dies, including measurement of serum Tg or TRAb, would help in 
differential diagnosis [6, 15, 21].
One more limitation of scintigraphic imaging is the lack of 
objective standards for interpretation of scintiscans of patients di-
agnosed due to CH.
Another problem is that even positive results of L-thyroxine 
withdrawal trial and visualisation of normal thyroid gland on scin-
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tiscan, excluding permanent forms of CH, do not always result in 
discontinuation of treatment. Some physicians and parents are 
unwilling to agree to cessation of L-thyroxine, being afraid of 
devastating implications of even slight thyroid dysfunction at the 
developmental age [19].
However, the diagnosis of the cause of CH with the use of 
scintigraphic imaging offers parents and physicians a chance to 
give the most effective counselling and lifetime prognosis of CH 
[19]. In such a context, the use of TcP may lead to overdiagnosis of 
thyroid ectopy; hence, 123I scintigraphy should be preferred.
The scintigraphic and sonographic picture of 
thyroid developmental anomalies
Thyroid agenesis
Thyroid agenesis is characterised by developmental failure of 
thyroid primordium or involution of thyroid anlage at the very early 
stages of embryogenesis. It results in a lack of functional thyroid tis-
sue, named athyreosis. It occurs with similar frequency in men and 
women. Thyroid agenesis is the cause of CH in 35–40% of cases [25]. 
On ultrasound examination the thyroid cannot be visualized, 
neither in its typical nor potential ectopic localizations. In the 
thyroid bed, only cystic structures of unknown origin and clinical 
significance can be observed (Figure 1) but not presenting as func-
tioning thyroid tissue on thyroid scintiscans [14]. Diagnosis of 
athyreosis is confirmed by thyroid scintiscan, where no radio-
isotope uptake is present in the head or neck region (Figure 2). 
This is consistent with undetectable levels of thyroglobulin.
Thyroid hypoplasia
Thyroid hypoplasia is a variant of incomplete morphogen-
esis of the thyroid gland, in which eutopic thyroid of proper shape 
presents decreased volume [13]. It is usually accompanied by 
hormonal dysfunction [26]. Five per cent of patients diagnosed 
with CH present thyroid hypoplasia [25]. It is usually caused by 
disturbances in the response of thyroid tissue to trophic action of 
TSH [26], which might be caused by mutations in TSH-R.
Thyroid presents on ultrasound examination as small, hypo-
trophic glands often of decreased echogenicity. The scintiscan 
demonstrates thyroid of proper localization, but the radionuclide 
uptake might be decreased. The thyroglobulin concentrations may 
vary, but most typically are lowered in comparison to subjects with 
thyroids of normal size.
One of the variants of this anomaly is hypoplasia of one thyroid 
lobe. It usually concerns the left side. One lobe hypoplasia is usu-
ally detected accidentally and is associated with less severe clinical 
consequences as it rarely results in hypothyroidism.
Thyroid ectopy
Ectopy refers to the presence of thyroid tissue in a localization 
different from that which is typical. It is the result of a disturbed 
process of descent of the thyroid primordium, which occurs dur-
ing embryogenesis. As a consequence, the thyroid might be 
located along the pathway of descent of the thyroid anlage [27]. 
Autopsy studies reveal that thyroid cells of ectopic location might 
be histopathologically visualized even in 10% of the population 
[28]. Most frequently the process of migration of the thyroid 
primordium is arrested at the very beginning, which results in 
localization of the gland at the base of the tongue. Lingual thyroid 
comprises close to 90% of all cases of thyroid ectopy [29]. The 
incidence of lingual thyroid is estimated at 1:100,000–1: 300,000 
in the population; however, it is probably far underestimated [30, 
31]. Another study suggests that the occurrence of thyroid ectopy 
is 1:2500–1:4000 patients with thyroid disease [32]. Ectopy 
is more prevalent in the female sex, with 4–7 fold predominance 
over males in cases of lingual thyroid [33, 34]. More rarely, sub-
lingual thyroid may occur, when the gland is located between the 
geniohyoid and mylohyoid muscles. Sporadic cases of ectopic 
gland are found in submandibular, prelaryngeal, supra-, or inf-
Figure 2. Thyroid agenesis. A. Tc-99m thyroid scintiscan. The radioisotope uptake entirely in salivary glands. No thyroid tissue is visible in cervical 
or any potential ectopic localization. B. Ultrasound picture (transverse section).
Figure 1. Cystic structure in the right thyroid bed (arrow) in a patient 
with thyroid agenesis. Note also the characteristic indentation of ster-
nothyroid and sternohyoid muscles into thyroid bed.
A B
 0 5 10 cm
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rahyoid location. Some cases of ectopy cannot be explained by 
disturbed descent of the thyroid anlage as thyroid cells can be 
found in a retrosternal localization inside the trachea, oesopha-
gus, or pericardial sack. Incidentally, ectopic thyroid was found in 
the retroperitoneum, sella turcica, urinary bladder, or ovary [27]. 
Due to the lack of the possibility of lateral expansion of the gland, 
the hormonal function of the ectopic thyroid is usually insufficient 
to provide adequate hormonal supply. Over 60% of patients with 
ectopy present with hypothyroidism of varying severity, from 
incidentally detected subclinical thyroid dysfunction to severe 
cases of CH [27, 35]. Thyroid ectopy is quoted as the cause of 
CH in 30–45% of cases [25]. Meanwhile, due to the preserved 
basic hormonal secretion, patients with thyroid ectopy are most 
likely to be missed in neonatal screening due to false-negative 
results of TSH assessment [36]. Figure 3 presents a scintigraphic 
and sonographic picture of lingual thyroid.
Thyroid haemiagenesis
Thyroid haemiagenesis (TH) is characterised by a congenital 
absence of one of the thyroid lobes. According to different re-
ports, in 68–88% of cases the left lobe is absent, and an isolated 
form of left lobe agenesis is most prevalently observed [37, 38]. 
Less frequently, left lobe and isthmus agenesis, or right lobe and 
isthmus absence can be found. The incidence of this anomaly 
is estimated to be 0.20–0.025% [39–42].
On ultrasound examination, only one thyroid lobe can be 
visualised. It might be enlarged as a result of prolonged ex-
position to increased TSH concentrations. The compensative 
enlargement might present as diffuse enlargement or nodular 
goitre. Decreased heterogeneous echogenicity is less unusual 
[38]. On the agenesis side, the indentation of the sternothyroid 
and sternohyoid muscles into the thyroid bed is observed, while 
the sternocleidomastoid muscle is located closer to the trachea 
instead of being separated by the thyroid lobe, as is visible on the 
contralateral side [43, 44].
The diagnosis of TH is established on the basis of sonographic 
assessment combined with scintiscan, which is performed to ex-
clude the presence of functional thyroid tissue on the contralateral 
side to the lobe demonstrated in ultrasonography, and to visualise 
potential accessory thyroid tissue located ectopically. Figure 4 
demonstrates a Tc-99m scintiscan and ultrasound picture of TH. 
In differential scintigraphic diagnosis of TH other thyroid patholo-
gies causing unilateral isotope uptake should be considered, 
sometimes known as “functional haemiagenesis”, i.e. autono-
mous nodule, primary, and metastatic neoplasms, amyloidosis, 
unilateral thyroiditis, postinflammatory atrophy, or status post 
hemithyroidectomy [45] (Figure 5).
Besides sonographic assessment, which is the method of 
choice in discriminating TH from the listed pathologies, other 
nuclear imaging techniques might be helpful, including 131I scin-
tiscan followed by rh-TSH stimulation, as well as imaging with 201Tl, 
Tc-99m-sestamibi or Tc-99m-tetrophosmin [46, 47].
Figure 3. Lingual thyroid. A. 131I scintiscan. B. Sonographic visualization 
of a lingual thyroid (transverse section).
A B
0 10 20 cm
A
 0 5 10 cm
B
Figure 4. Left-sided thyroid haemiagenesis. A. Tc-99m scintiscan. 
B. Sonographic picture (transverse section).
Figure 5. Pathological conditions that, beside thyroid haemiagenesis, should be included in differential diagnosis of unilateral isotope uptake 
(Tc-99m scintiscans). A. Autonomous nodule. B. Unilateral subacute thyroiditis. C. Status post hemithyr oidectomy.
A B C
0 5 10 cm 0 5 10 cm 0 5 10 cm
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As the function of one thyroid lobe is usually sufficient to 
provide adequate hormonal production, TH is considered harm-
less thyroid developmental variant, rarely leading to CH. In the 
study by Al Taji et al., TH was the cause of CH in 1 out of 170 
patients; in the study by Ramos et al. it was the cause in 1% of 
patients; and in the study by Devos et al. it was the cause in 1 
out of 230 newborns with permanent CH [26, 48, 48]. More often, 
it is responsible for transient hyperthyrotropinaemia or compen-
sated hypothyroidism, which during neonatal screening is more 
often detected at birth [50]50. Most cases of TH, however, are 
detected in adulthood. Due to its subclinical course, TH is usually 
diagnosed incidentally during diagnostics of concomitant thyroid 
diseases or imaging procedures performed due to other indica-
tions or as screening examinations.
Scintigraphic and sonographic visualisation 
of other thyroid developmental variants
Accessory thyroid gland
This term signifies the presence of additional thyroid tissue 
in an ectopic location, apart from properly formed and located 
thyroid gland. This anomaly is predominantly clinically silent and 
is detected accidentally during thyroid imaging performed due to 
concomitant thyroid pathology. Figure 6 demonstrates accessory 
thyroid gland in a patient referred for diagnostics of nodular goitre.
Sometimes, when an accessory thyroid enlarges, it might 
present as a lingual or neck mass and only biopsy or scintigraphic 
examination might confirm the presence of thyroid tissue. Some-
times, patients might experience local compressive symptoms; 
however, it rarely leads to hormonal imbalance. Hyperthyroidism 
might be observed only in the case of autonomisation of thyroid 
tissue [51]. It should be remembered that the accessory gland may 
also undergo nodular changes (Figure 7) and even be the site of 
cancer origin, hence requiring careful sonographic assessment 
because small lesions may not alter the radioisotope uptake in 
thyroid scintiscans.
Thyroglossal duct cyst
Thyroglossal duct cysts comprise close to 7% of congeni-
tal neck masses [52]. They occur with a similar prevalence in 
males and females [53]. Thyroglossal duct is a structure that 
joins the tongue with descending thyroid anlage, and it under-
goes involution after the thyroid has completed its descent [54]. 
However, in some cases it does not disappear and its lumen 
fills with fluid. In the wall of the cyst nests of thyroid cells might 
be located, which in 1–2% of cases might undergo neoplastic 
transformation (Figure 8). The most common localization is midline 
in the infrahyoid region of the neck (60%). Less frequently, loca-
tions involve suprahyoid region as well as lingual, intralaryngeal, 
and retrosternal localizations [53, 55].
Clinically, thyroglossal duct cyst presents as painless, mov-
able neck mass. Motility of the cyst along with the tongue move-
ments is pathognomonic. The cyst is filled with serous fluid, and 
sonographically it presents as an anechogenic lesion with regular 
borders and posterior enhancement. In cases of infection, the cyst 
A B
 0 5 10 cm
Figure 6. Accessory thyroid gland. A. Tc-99m scintiscan. B. Sonographic picture.
Figure 7. Accessory thyroid gland, with an isoechogenic lesion inside 
— ultrasound picture (transverse section).
Figure 8. Ultrasound picture of papillary cancer, presenting as cluster 
of calcifications in a thyroglossal duct cyst.
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fills with pus and the fluid inside might contain dense hyperecho-
genic structures [56]. However, it is important to check the cyst for 
the presence of thyroid cells in the wall of the cyst, which is only 
possible by scintigraphic examination [57] (Figure 9). 
Pyramidal lobe
Adequate classification of pyramidal lobe as an anatomical or 
pathological structure is still unclear. Due to the commonness of 
its incidence, it is regarded as one of the morphological variants of 
normal thyroid [58, 59]. In fact, the pyramidal lobe is a remnant 
of the caudal part of the thyroglossal duct and signifies the path 
of descent of thyroid primordium during embryogenesis [54]. 
Remnants of thyroglossal duct are reported to be found in 29 to 
80% of cases [60]. Pyramidal lobe occurs with similar frequency in 
men and women, but in females it tends to be longer, with an ave-
rage size of 29 mm in comparison to males, with pyramidal lobe 
14 mm long on average [61]. In some cases it might arise above 
the lobes or even up to the hyoid bone [62]. It is connected with 
the thyroid at the left part of the isthmus; rarely it arises from the 
midline or left thyroid lobe [61]. Pyramidal lobe can sometimes be 
visualized by imaging. On thyroid scintiscan, it is detected in over 
half of the cases of toxic parenchymal goitre or in patients after 
thyroidectomy, but in only 10% of healthy subjects [63]. It is formed 
from normal thyroid tissue and hence might undergo nodular or 
neoplastic transformation [60]. Figure 10 represents a pyramidal 
lobe of significant size in a patient with right-sided TH, visible in 
both ultrasonographic and scintigraphic imaging.
Conclusions
Awareness of both the advantages and limitations of sono-
graphic and scintigraphic imaging is the key to successful inter-
pretation of their results and reasonable recommendation of these 
procedures for patients with thyroid developmental anomalies of 
different age and clinical picture.
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